Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 3Phase 3 1

Status

Unknown 2Terminated 2Recruiting 1Completed 1

Sponsor Class

OTHER 10INDUSTRY 6OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 687Breast Neoplasms 585Neoplasms 468Colorectal Neoplasms 300Prostatic Neoplasms 263Neoplasm Metastasis 257Melanoma 242Ovarian Neoplasms 228Recurrence 216Lung Neoplasms 203Multiple Myeloma 196Lymphoma, Non-Hodgkin 155Pancreatic Neoplasms 154Leukemia, Myeloid, Acute 142Carcinoma, Hepatocellular 141Stomach Neoplasms 137Lymphoma 131Carcinoma, Renal Cell 128Glioblastoma 118Squamous Cell Carcinoma of Head and Neck 113Head and Neck Neoplasms 113Lymphoma, Follicular 106Leukemia, Lymphocytic, Chronic, B-Cell 99Small Cell Lung Carcinoma 96Lymphoma, Large B-Cell, Diffuse 96Leukemia 96Brain Neoplasms 91Carcinoma 82Uterine Cervical Neoplasms 77Triple Negative Breast Neoplasms 73

Interventions

Gemcitabine 2tusamitamab ravtansine 1margetuximab 1exemestane 1Vinorelbine 1Trastuzumab 1Tamoxifen 1Letrozole 1Fulvestrant 1Capecitabine 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Breast Cancer Metastatic × Clear all
NCT04059484 2026-02-24

AMEERA-3

Sanofi

Phase 2 Terminated
367 enrolled 30 charts
Breast

Breast Cancer Metastatic

NCT04659603 2025-10-01

CARMEN-BT01

Sanofi

Phase 2 Terminated
50 enrolled 20 charts
BreastGastrointestinal

Breast Cancer Metastatic

NCT05420779 2024-05-08

A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations

Tasly Pharmaceutical Group Co., Ltd

Phase 2 Recruiting
125 enrolled
Breast

Breast Cancer Metastatic

NCT04262804 2023-08-22

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

Zai Lab (Hong Kong), Ltd.

Phase 2 Unknown
123 enrolled
Breast

Breast Cancer Metastatic

NCT04556292 2020-09-21

A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Phase 2 Unknown
78 enrolled
Breast

Breast Cancer Metastatic

NCT02664103 2018-02-01

METRO-ABC

Sanofi

Phase 2 Completed
2 enrolled
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡